Step 1 topics → Biochemistry → Cytoskeleton

Cytoskeleton

USMLE Step 1 trap: Inverts kinesin and dynein directionality on microtubules. Kinesin moves cargo toward the plus end (anterograde, toward periphery); dynein moves cargo toward the minus end (retrograde, toward the cell body/nucleus).

The cytoskeleton is one of those topics that looks simple on a table but gets messy fast when the exam asks you to apply it. There are three types — microtubules, microfilaments (actin), and intermediate filaments — and USMLE Step 1 doesn't just want you to memorize them. It wants you to know which motor protein goes which direction, which filament marks which tumor, and how two different drug classes can both block mitosis through opposite mechanisms. The concept shows up in biochemistry, pathology, and pharmacology questions, often embedded in a clinical vignette about cancer treatment or a pathology slide.

The trickiest part is that the exam tests this from multiple angles simultaneously. A single question might describe a patient on a chemotherapy regimen and ask you to identify the mechanism — forcing you to distinguish taxanes from vinca alkaloids. Another might give you an immunohistochemistry result on a soft tissue mass and ask what it implies about tumor origin. USMLE Step 1 loves to test intermediate filament markers in the context of tumor identification because it combines cell biology with clinical pathology, and students who only memorized 'cytoskeleton = structural support' get destroyed on these.

The three biggest traps: mixing up kinesin and dynein directionality (students almost always flip them), failing to connect specific intermediate filaments to specific tissue types, and assuming taxanes and vinca alkaloids work the same way just because they both target microtubules. If you can nail those three, the cytoskeleton becomes a reliable point-getter rather than a coin flip.

From real student decks
100%have cards covering this topic
81%have mature cards

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: Dynein moves cargo toward the cell periphery (anterograde).
Right: Kinesin moves cargo toward the plus end (anterograde, toward periphery); dynein moves cargo toward the minus end (retrograde, toward the cell body/nucleus).
Dynein does NOT move cargo toward the periphery — that's kinesin's job. Microtubules are oriented with their plus ends pointing outward (toward the cell membrane) and their minus ends anchored near the nucleus/centrosome. Kinesin walks toward the plus end, so it carries cargo away from the nucleus (anterograde transport, e.g., vesicles heading to the synapse). Dynein walks toward the minus end, so it hauls cargo back toward the nucleus (retrograde transport, e.g., endosomes or pathogens being transported centrally). A useful anchor: 'K for kinesin, K for away from the nucleus' — or just remember dynein rhymes with 'down into' the cell body.
Common mistake
Gap: Fails to match specific intermediate filament markers to their corresponding tumor types
Vimentin marks mesenchymal tumors (sarcomas), desmin marks muscle tumors, GFAP marks glial tumors, and cytokeratin marks epithelial tumors — each intermediate filament is tissue-specific.
Intermediate filaments are tissue-specific by design, which is exactly why pathologists use them as IHC markers — the filament a tumor expresses tells you what tissue it came from. Vimentin is expressed in mesenchymal cells, so sarcomas stain vimentin-positive. Desmin is the filament of muscle cells, so rhabdomyosarcomas and other muscle tumors stain desmin-positive. GFAP (glial fibrillary acidic protein) marks astrocytes and glial tumors like glioblastoma. Cytokeratin marks epithelial cells, so carcinomas are cytokeratin-positive. Memorize these four pairings as a clean set: vimentin-sarcoma, desmin-muscle, GFAP-glial, cytokeratin-carcinoma.
Common mistake
Wrong: Both taxanes and vinca alkaloids depolymerize microtubules.
Right: Vinca alkaloids prevent polymerization (depolymerize microtubules), while taxanes stabilize polymerized microtubules and prevent depolymerization; both block mitosis.
Taxanes and vinca alkaloids both wreck mitosis, but they do it in opposite ways — this is a favorite distinction on USMLE Step 1. Vinca alkaloids (vincristine, vinblastine) bind free tubulin and prevent it from polymerizing into microtubules, so the mitotic spindle can't form in the first place. Taxanes (paclitaxel, docetaxel) do the opposite: they bind to already-formed microtubules and hyperstabilize them, locking them in place so they can't depolymerize. Both strategies prevent the spindle from doing its dynamic job of separating chromosomes, but the molecular target and direction of disruption are completely different. Think of it as: vincas = no assembly, taxanes = no disassembly.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the three cytoskeleton types (microtubules, microfilaments, intermediate filaments), their subunit proteins (tubulin, actin, tissue-specific IFs), and their distinct cellular functions — structural support, cell motility, intracellular transport, and cell division.
  2. Know that kinesin moves cargo anterograde (toward the plus end, toward the cell periphery) and dynein moves cargo retrograde (toward the minus end, toward the cell body/nucleus) — and be able to apply this to axonal transport scenarios.
  3. Know which intermediate filament protein corresponds to which tissue and tumor type: vimentin for mesenchymal/sarcomas, desmin for muscle tumors, GFAP for glial tumors, cytokeratin for epithelial tumors, neurofilaments for neurons — and use this to interpret IHC findings in a tumor vignette.
  4. Know that vinca alkaloids (vincristine, vinblastine) prevent microtubule polymerization while taxanes (paclitaxel) stabilize polymerized microtubules and prevent depolymerization — both arrest mitosis, but through mechanistically opposite effects on microtubule dynamics.

Can you avoid these mistakes?

A neuron is transporting a lysosome containing degraded material from the axon terminal back to the cell body. Which motor protein is responsible, and in which direction along the microtubule is it moving?
A 55-year-old woman is found to have a soft tissue mass in her thigh. Biopsy immunohistochemistry shows the tumor cells are positive for vimentin and negative for cytokeratin, desmin, and GFAP. What is the most likely tumor type, and what does this IHC pattern tell you about its cell of origin?
A patient with ovarian cancer is being treated with paclitaxel. Your classmate says 'it works just like vincristine — both destroy microtubules.' What is wrong with this explanation, and how do the two mechanisms actually differ?
A medical student draws a diagram of a cell and labels the centrosome as the 'minus end anchor' of microtubules, with plus ends extending outward. If kinesin attaches to a secretory vesicle near the nucleus, where will it deliver that vesicle, and what would happen to vesicle delivery if kinesin were replaced by dynein?

Related topics

Organelle Functions Nucleotide and Nucleic Acid Structure DNA Replication DNA Repair Pathways Mutations and Their Consequences

See how your Anki deck covers this topic.

Upload your deck for a free audit →